Receptor map uncovers hidden sites that could guide asthma drug design

AI Summary

Researchers at the Center for Genomic Regulation developed a method to identify previously hidden drug-binding sites on a family of receptors. The findings may help guide asthma drug design and potentially inform treatments for other conditions with fewer side effects.

Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression.